The introduction of nanocrystalline therapy technology into major tertiary hospitals is also very fast. It is expected that by the end of the year, nearly 500 hospitals will introduce nanocrystalline therapy, which can basically radiate to all parts of the country. Due to expensive medical equipment and medical agents, domestic hospitals will also cost US$30 million, or about RMB 189 million.

No wonder foreigners criticize Huasheng Technology as an "Oriental vampire". Foreigners will spend more than 1.26 billion RMB to purchase a set of nanocensor therapy equipment, which is $200 million. The use of technology monopoly is to bully you without technology and rely on it to save your life.

Huasheng Pharmaceutical's production lines are constantly expanding, and the investment in production lines alone is no less than 100 billion yuan. Coupled with production capacity consumption, it is even more of an astronomical figure.

In order to achieve the production of 470 sets of nanogauge treatment equipment by the end of the year, nearly 80 billion yuan of cost expenditure must be invested here. At the same time, more than 10,000 doses of pharmaceuticals per set of equipment are equipped for this, that is, more than 5 million courses of medicines, and more than 500 billion yuan of manufacturing costs must be used here.

Fortunately, Huasheng Group has strong cash reserves and has not been handed over to institutions such as hedging genes to preserve its value. The big sale of H1S mobile phones and the money tree of Peanut Network have given Huasheng Group an additional $50 billion in cash reserves last year, and the funds saved by the previous year also had nearly $9 billion in cash reserves.

It has been more than half a year this year, and H1S phones continue to sell 60 million units. Although foreigners have scolded Huasheng Group because of the recent hot topics of nanocensor therapy technology, no matter how much they scold, they still have to buy what they should buy.

Who makes H1S mobile phones stand out?

The shipments of 60 million H1S mobile phones have generated more than US$90 billion in revenue for Huasheng Technology, and Peanut Network has also generated US$46 billion in revenue worldwide.

The two major subsidiaries hit US$136 billion in the first half of this year, of which the net profit was US$47.6 billion, and their profitability was scary. In half a year, these two subsidiaries could surpass Apple's annual profit before the impact of Washington.

In other words, the current Huasheng Group has a huge cash reserve of more than US$100 billion, which is approximately 672.646 billion soft sister coins.

It just can meet the huge capacity costs required by Huasheng Pharmaceutical, and the remaining funds can also meet the high cost expenditures of Huasheng Group's daily operations, and it can also make some balances.

It was also considered to be a response to Li Chuan's call, and the money you earned should not be kept in your hands and had to be spent.

However, the more money you spend, the more you make. The 470 sets of nanogauge therapy equipment and more than 5 million gram therapy drugs combined will cost more than 600 billion yuan, which also means that it will generate up to 970 billion yuan in revenue, that is, revenue of US$154.3 billion.

This is just a domestic order of more than 700 billion US dollars signed by foreign countries. According to the cooperation agreement, the 260 billion US dollars of this year can be recovered.

In other words, Huasheng Pharmaceuticals can generate US$414.3 billion in revenue this year, and the revenue of two wholly-owned subsidiaries, Huasheng Electronics and Peanut Network, is expected to be US$250 billion. The entire Huasheng Group's revenue this year is expected to reach an astonishing US$674.3 billion.

This revenue directly killed Walmart, which ranked first in the world's top 500, and Huasheng Group will become the double champion in revenue and profit among the world's top 500 companies.

Among this account, Huasheng Pharmaceuticals has a revenue of US$154.3 billion and a net profit of US$20.6 billion due to free concessions in China. The profit is already very high. This is on the premise that Huasheng Group makes free concessions to vulnerable groups in society. If Li Chuan is a little unscrupulous, he can completely increase his net profit to US$77.15 billion. You should know that this is a super profitable industry.

And the super fat order overseas is a real super profitable profit.

In general, Huasheng Group's net profit is expected to reach US$238.1 billion this year, and the probability of bad debts is zero. That is to say, after the end of the year, Huasheng Group's wallet will have more than US$200 billion in cash reserves.

There was only one company in the world that had cash reserves of more than $200 billion, and that was Apple, but a second company would soon be born, that was Huasheng Group.

It took Apple decades to do it, and it only took a year for Huasheng Group to take such a terrifying profitability, and it is scary to say it out.
Chapter completed!